Hypofractionated radiation therapy alone for human papillomavirus‐related oropharyngeal cancer
Head & Neck · 2025
DOI: 10.1002/hed.27908 ↗Kurz gefasst
Fachartikel in der Zeitschrift Head & Neck, 2025. Verfasst von Allen M Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, University of California, Irvine, Chao Family Comprehensive Cancer Center, Orange, California, USA. Hauptthemen laut MEDLINE: Oropharyngeal Neoplasms, Radiation Dose Hypofractionation, Papillomavirus Infections. Die Arbeit nennt 25 Literaturangaben.
Abstract (Originalsprache)
Purpose
To report a single‐institutional experience with hypofractionated radiation therapy alone for human papillomavirus (HPV)‐positive oropharyngeal cancer. Methods and materials A total of 101 consecutive patients were treated by radiation therapy alone using a regimen of 66 Gy in 30 fractions (60 patients) or 70 Gy in 33 fractions (41 patients) for newly diagnosed p16‐positive squamous cell carcinoma of the oropharynx. Sixty‐seven patients (67%) were never smokers.
Results
The 3‐year actuarial rates of overall survival, local‐regional control, and progression‐free survival were 94%, 93%, and 89%, respectively. Among never‐smokers, the 3‐year rates of overall survival and local–regional control were 98% and 100%, respectively. The grade 3+ acute toxicity rate was 21%, with the most commonly observed side effects related to mucositis.
Conclusion
Hypofractionated radiation alone resulted in excellent outcomes for patients with HPV‐positive oropharyngeal cancer. A prospective clinical trial investigating this modality in the setting of de‐escalation is currently underway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, University of California, Irvine, Chao Family Comprehensive Cancer Center, Orange, California, USA.
- Department of Otolaryngology, University of California, Irvine, Chao Family Comprehensive Cancer Center, Orange, California, USA.
Zitieren
APA
Chen, A. M., Harris, J. P., Tjoa, T., Haidar, Y., & Armstrong, W. B. (2025). Hypofractionated radiation therapy alone for human papillomavirus‐related oropharyngeal cancer. Head & Neck. https://doi.org/10.1002/hed.27908
Vancouver
Chen AM, Harris JP, Tjoa T, Haidar Y, Armstrong WB. Hypofractionated radiation therapy alone for human papillomavirus‐related oropharyngeal cancer. Head & Neck. 2025. doi:10.1002/hed.27908
BibTeX
@article{Chen2025,
author = {Chen, Allen M and Harris, Jeremy P and Tjoa, Tjoson and Haidar, Yarah and Armstrong, William B},
title = {Hypofractionated radiation therapy alone for human papillomavirus‐related oropharyngeal cancer},
journal = {Head & Neck},
year = {2025},
doi = {10.1002/hed.27908}
}
EUVIMED